Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1993-01-28
1994-11-15
Henley, III, Raymond J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
A61K 3119
Patent
active
053646444
ABSTRACT:
The present invention provides a formula and method for the prevention and treatment of hypercholesterolemia and cellular hyperproliferation. More specifically, the present invention provides a method for administering a formula including glucaric acid or a pharmaceutically acceptable salt thereof for the prevention and treatment of hypercholesterolemia and cellular hyperproliferation in humans and animals. It has been determined that glucaric acid and pharmaceutically acceptable salts thereof significantly lower the total and LDL level of serum cholesterol and inhibit cellular hyperproliferation when administered in therapeutic amounts. It is intended that glucaric acid or a pharmaceutically acceptable salt thereof is employed alone or in combination with other medicinal agents for the prevention and treatment of hypercholesterolemia and cellular hyperproliferation.
REFERENCES:
patent: 3697287 (1972-10-01), Winitz
patent: 4740373 (1988-04-01), Kesselman et al.
patent: 4751085 (1988-06-01), Gaull
patent: 4845123 (1989-07-01), Walaszek et al.
patent: 4997852 (1991-03-01), Minton et al.
patent: 5008291 (1991-04-01), Minton et al.
patent: 5010107 (1991-04-01), Minton et al.
Walaszek et al., "Antiproliferative Effects of Calcium D-Glucarate (CG) and D-Glucaro-1,4-Lactone (GL) on the Rat Mammary Gland, Colon and Mouse Skin," AACR Abstract Form (1990) printed in USA.
Walaszek et al., "Antiproliferative Effect of Dietary Glucarate on the Sprague-Dawley Rat Mammary Gland," Cancer Letters, 49:51-57, (1990), published in Ireland.
Product Information, Merck, Sharp & Dohme, 1413 (1989), published in USA.
Abou-Issa et al., "Putative Metabolites Derived from Dietary Combinations of Calcium Glucarate and N-(4-hydroxyphenyl) Retinamide Act-Synergistically to Inhibit the Induction of Rat Mammary Tumors by 7,12-dimethylbenz[a]anthracene," Proc. Natl. Acad. Sci. USA, 85:4181-4184 (1988) published in USA.
The United States Pharmacopeia, the National Formulary, Twenty-First Revision (Jan. 1, 1985), p. 48, Calcium Gluconate, published in USA.
Alberts et al., "Mevinolin: A Highly Potent Competitive Inhibitor of Hydroxymethylglutaryl-coenzyme A Reductase and a Cholesterol-lowering Agent," Proc. Natl. Acad. Sci. USA, 77(7):3957-3961 (1980), published in USA.
Merck Index, p. 240, #1720 Candicidin, published in USA (1982).
Schneeman et al., "Similar Effects of Zinc Deficiency and Restricted Feeding on Plasma Lipids and Lipoproteins in Rats," J. Nutr., 116:1889-1895 (1986), published in USA.
Garrison and Somer, "Vitamins and Minerals: Their Relationship to Cardiovascular Disease," the Nutrition Desk Reference, Keats Publishing, Inc., New Canaan, Conn., Chapter 14, pp. 172-180 (1985), published in USA.
Babiak et al., "Effects of Dietary Polyunsaturated and Saturated Fats on Lipoproteins in the Baboon," Atherosclerosis, 57:1-17 (1985), published in Ireland.
Levvy, "The Preparation and Properties of .beta.-Glucuronidase. 4. Inhibition by Sugar Acids and Their Lactones," Biochem., 52:464-472 (1952), published in USA.
Boyland et al., "An Attempt to Prevent the Induction of Bladder Cancer in Dogs with 1.fwdarw.4-Gluco-Saccharolactone," Investigative Urology, 2(5):439-445 (1965), published in USA.
Bradley, "Effect of a .beta.-Glucuronidase Inhibitor and Methylcholanthrene on the Induction of Bladder Tumors in Rats," the Journal of Urology, 55(5):626-628 (1962), published in USA.
Iida et al., "2,5-DI-O-Acetyl-D-Glucosaccharo-(1-4), (6-8)-Dilactone, A New Potent .beta.-Glucuronidase Inhibitor," Jap. J. Pharmacol., 15:88-90 (1955), published in Japan.
Miyakawa et al., "The Effect of Urinary .beta.-Glucuronidase Inhibitor on the Induction of Bladder Tumors with 2-Acetylaminofluorene in Rats," Investigative Urology, 10(4):256-261 (1973), published in USA.
Kazuo et al., "Studies on Experimental Bladder Tumors. Report 3. Exzymologicl and Histological Study of the Effects of Both .beta.-Glucuronidase Inhibitor and X-Ray Irradiation on Rat BBN Bladder Tumor," Chemical Abstracts, 86:361-362 (1977), Abstract No. 41460u, published in USA.
Takada et al., "Effect of .beta.-Glucuronidase Inhibitor on Azoxymethane-Induced Colonic Carcinogenesis in Rats," Cancer Research, 42:331-334 (1982), published in USA.
Boyland et al., "Attempted Prophylaxis of Bladder Cancer with 1.fwdarw.4 glucosaccharolactone," British Journal of Urology, 36:563-569 (1964), published in United Kingdom.
Katayama, "A Study on Prophylaxis for Recurrence of Bladder Tumor," 63(11):951-971 (1972), published in Japan.
Walaszek et al., "Inhibition of 7,12-Dimethylbenzanthracene-Induced Rat Mammary Tumorigenesis by 2,5-di-O-acetyl-D-glucaro-1,4:6,3-dilactone, an in vivo .beta.-glucuronidase Inhibitor," carcinogenesis, 5(6):767-772 (1984), published in United Kingdom.
Rawson et al., "Summation and Future Challenges," In: Inhibition of Tumor Induction and Development, Zedeck and Lipkin, editors, Plenum Press, New York, publishers, Chapter 9, pp. 219-223 (1981), published in USA.
Willett et al., "Relation of Serum Vitamins A and E and Carotenoids to the Risk of Cancer," the New England Journal of Medicine, 310(7):430-434 (1984), published in USA.
Walaszek et al., "Inhibition of 7,12-Dimethylbenzanthracene-Induced Rat Mammary Tumorigenesis by 2,5-DI-O-Acetyl-D-Glucaro-1,4:6,3-/Dilactone (Dagdl), an in Vivo .beta.-Glucuronidase Inhibitor," Proceedings of the Seventh-Fifth Annual Meeting of the American Association for Cancer Research, May 9-12, (1984), 25:128, Abstract No. 507, published in Canada.
Furuno et al., "Preventive Effect of D-Glucarate against Renal Damage Induced by Kanamycin," Chemical Abstracts, 85:45 (1976), Abstract No. 154048p, published in USA.
Furuno et al., "Effect of D-Glucarates on Basic Antiobiotic-Induced Renal Damage in Rats," Chemical Abstracts, 84:41 (1976), Abstract No. 115903y, published in USA.
The Merck Manual of Diagnosis and Therapy, Fourteenth Edition, Robert Berkow, M.D., Editor-in-Chief, Merck Sharp & Dohme Research Laboratories, Publishers, Chapter 82, "Anomalies in Lipid Metabolism," pp. 970-977(1982), published in USA.
Walaszek et al., "Effect of Calcium D-Glucarate on Development of the Rat Mammary Gland and Its Sensitivity to Chemical Carcinogenesis," and D-Glucarate Control of Intestinal Bacterial Microflora and Relationship to Cancer Prevention, Proceedings of the American Association for Cancer Research, 33:164 (1992), Abstract Nos. 981 and 982, published in USA.
Hanausek Margaret
Slaga Thomas J.
Walaszek Zbigniew
Board of Regents , The University of Texas System
Henley III Raymond J.
LandOfFree
Formula and method for the prevention and treatment of hyperchol does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Formula and method for the prevention and treatment of hyperchol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formula and method for the prevention and treatment of hyperchol will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1095824